AXSOME THERAPEUTICS, INC.— Sankey Diagram
Annual mode · period ending 2025-12-31 · SEC EDGAR
FY2025 - Q4(Oct 25 · Nov 25 · Dec 25)
Total Assets
$690M
↑+21.3% +$121Mvs FY2024
Total Liabilities
$602M
↑+17.6% +$90Mvs FY2024
Equity
$88M
↑+54.9% +$31Mvs FY2024
Cash
$323M
↑+2.4% +$8Mvs FY2024
Click a Metric or Sankey Node to View Historical Trends
Show Source Data (Audit Panel)
| Line item | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $690M | $568M |
| Current Assets | $589M | $485M |
| Cash | $323M | $315M |
| ST Investments | $0 | $0 |
| Receivables | $224M | $142M |
| Inventory | $28M | $16M |
| Other Current | $14M | $12M |
| Non-Current Assets | $101M | $83M |
| PPE | $562K | $584K |
| Goodwill | $12M | $12M |
| Intangibles | $41M | $47M |
| Investments | $0 | $0 |
| Other Non-Current | $48M | $24M |
| Total Liab+Eq | $690M | $568M |
| Current Liab. | $379M | $230M |
| Accounts Payable | $66M | $72M |
| Short-Term Debt | $0 | $0 |
| Deferred Revenue | $0 | $0 |
| Other CL | $313M | $158M |
| Non-Current Liab. | $223M | $281M |
| Long-Term Debt | $118M | $181M |
| Other LT Liab. | $105M | $101M |
| Equity | $88M | $57M |
| Retained Earnings | $1.31B | $1.12B |
| Other Equity | $0 | $0 |
QuarterCharts · SEC EDGAR data · AXSM · Comparing FY2025 vs FY2024